When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMS - Trevi Therapeutics IPO: At Phase 3 Of Development
Adamas Pharmaceuticals Inc.
With one candidate at Phase 3 of development, Trevi Therapeutics (TRVI) should interest IPO investors. Besides, the market will probably like the massive market opportunity. The total market for pruritus therapeutics was $11.09 billion in 2018. With that, it is not ideal that the company expects to deliver top-line data in the first half of 2020. Investors may have to wait some months to see the share price move.